Continued clinical investigation is essential to fully realize the potential of OSM and IL-6 family cytokine modulation, which could revolutionize therapeutic approaches for retinal diseases and enhance patient outcomes (Figure 1). The gene discussed is IL6; the disease is Abnormal retinal morphology.